These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 44693)

  • 21. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording.
    Grace AA; Bunney BS
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1092-100. PubMed ID: 3746660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indirect evidence for a feedback loop mechanism between two central dopaminergic pathways: preliminary results.
    Yehuda S
    Commun Psychopharmacol; 1979; 3(2):115-9. PubMed ID: 467002
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function.
    Matthews RT; McMillen BA; Sallis R; Blair D
    J Pharmacol Exp Ther; 1986 Oct; 239(1):124-31. PubMed ID: 2876091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
    Arushanian EB
    Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
    Humpel C; Knaus GA; Auer B; Knaus HG; Haring C; Theodorsson E; Saria A
    Synapse; 1990; 6(1):1-9. PubMed ID: 1697986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor plasticity: biochemical correlates and pharmacological significance.
    Costa E
    Adv Biochem Psychopharmacol; 1980; 24():363-77. PubMed ID: 6105787
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of the effects of anti-psychotic drugs on pituitary, striatal and limbic system post-synaptic dopamine receptors.
    Meltzer HY; Simonovic M; Fang V; Piyakalamala S; Young M
    Life Sci; 1978 Aug; 23(6):605-9. PubMed ID: 29199
    [No Abstract]   [Full Text] [Related]  

  • 28. Limbic selectivity of clozapine.
    Longhurst J
    Lancet; 1997 Nov; 350(9088):1399-400. PubMed ID: 9365474
    [No Abstract]   [Full Text] [Related]  

  • 29. Mesolimbic system and tardive dyskinesia: new perspectives for therapy.
    Cools AR
    Mod Probl Pharmacopsychiatry; 1983; 21():111-23. PubMed ID: 6140628
    [No Abstract]   [Full Text] [Related]  

  • 30. Induction of dopaminergic mesolimbic receptor supersensitivity by haloperidol.
    Davis KL; Hollister LE; Fritz WC
    Life Sci; 1978 Oct; 23(15):1543-8. PubMed ID: 723433
    [No Abstract]   [Full Text] [Related]  

  • 31. Limbic selective neuroleptics.
    Bischoff S
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():265A-266A. PubMed ID: 1354032
    [No Abstract]   [Full Text] [Related]  

  • 32. Electrophysiological studies of the role of cholecystokinin in the substantia nigra and its interactions with dopamine.
    Skirboll LR; Hommer DW
    Ann N Y Acad Sci; 1985; 448():275-82. PubMed ID: 3861121
    [No Abstract]   [Full Text] [Related]  

  • 33. 5-HT3 antagonists and ligands for dopamine D1- and autoreceptors offer new leads for antipsychotic drugs.
    Abbott A
    Trends Pharmacol Sci; 1990 Feb; 11(2):49-51. PubMed ID: 1969187
    [No Abstract]   [Full Text] [Related]  

  • 34. Dopamine receptor stimulants in hypertension.
    Clark BJ
    Acta Med Scand Suppl; 1977; 606():95-100. PubMed ID: 268936
    [No Abstract]   [Full Text] [Related]  

  • 35. Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy.
    Friedman JI; Lindenmayer JP; Alcantara F; Bowler S; Parak M; White L; Iskander A; Parrella M; Adler DN; Tsopelas ND; Tsai WY; Novakovic V; Harvey PD; Davis KL; Kaushik S
    Neuropsychopharmacology; 2011 May; 36(6):1289-95. PubMed ID: 21346734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats.
    Lacombe E; Carcenac C; Boulet S; Feuerstein C; Bertrand A; Poupard A; Savasta M
    Eur J Neurosci; 2007 Sep; 26(6):1670-80. PubMed ID: 17822436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methamphetamine discrimination and in vivo microdialysis in squirrel monkeys.
    Czoty PW; Makriyannis A; Bergman J
    Psychopharmacology (Berl); 2004 Sep; 175(2):170-8. PubMed ID: 15064912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons.
    Marinelli M; White FJ
    J Neurosci; 2000 Dec; 20(23):8876-85. PubMed ID: 11102497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apomorphine induced cognitive changes in Parkinson's disease.
    Růzicka E; Roth J; Spacková N; Mecír P; Jech R
    J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):998-1001. PubMed ID: 8057129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CGP 25454A, a novel and selective presynaptic dopamine autoreceptor antagonist.
    Bischoff S; Baumann P; Krauss J; Maître L; Vassout A; Storni A; Chouinard G
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):230-8. PubMed ID: 7824038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.